Devices › Intervertebral fusion device with bone graft, lumbar
Device brand name · Intervertebral fusion device with bone graft
Catalyft PL Expandable Interbody System: medical device reports filed with FDA
378 reports name it, 2022–2026. Manufacturer given most often on reports: Warsaw Orthopedics. Product code MAX.
- 378
- device reports naming the brand
- 0% of all MAUDE reports · about 84 a year
- 95
- reports, 12 months to August 2026
- 167 in the 12 months before
- 74.9%
- classified as malfunction
- 63.3% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
378 medical device reports received by FDA name the brand "Catalyft PL Expandable Interbody System" (intervertebral fusion device with bone graft); the manufacturer given most often on reports is Warsaw Orthopedics; received from January 2022 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
95 reports arrived in the 12 months to August 2026, down 43% from 167 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (74.9%) and injury (25.1%); across all intervertebral fusion device with bone graft, lumbar reports (product code MAX) death is recorded in 0.3% and malfunction in 63.3%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are mechanical problem (61.9%), migration (19.6%) and mechanics altered (11.1%). The patient problems coded most often are pain, inadequate osseointegration and back pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 9,238 reports carrying product code MAX. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Mechanical problema mechanical problem | 234 | 61.9% | 5.7% |
| Migrationthe device moved from where it was placed | 74 | 19.6% | 8.5% |
| Mechanics altered | 42 | 11.1% | 1.3% |
| Breakthe device broke | 21 | 5.6% | 28.7% |
| Device dislodged or dislocated | 6 | 1.6% | 2.1% |
| Migration or expulsion of device | 5 | 1.3% | 6.8% |
| Collapse | 4 | 1.1% | 2.3% |
| Malposition of device | 2 | 0.5% | 1.3% |
| Mechanical jam | 2 | 0.5% | 1.8% |
| Off-label use | 2 | 0.5% | 0.1% |
| Product quality problem | 2 | 0.5% | 0.1% |
| Detachment of device or device componentpart of the device came off | 1 | 0.3% | 1.1% |
| Device handling problem | 1 | 0.3% | 0.2% |
| Difficult or delayed positioning | 1 | 0.3% | 0.1% |
| Expulsion | 1 | 0.3% | 0.1% |
| Loosening of implant not related to bone-ingrowth | 1 | 0.3% | 0.3% |
| Material deformation | 1 | 0.3% | 2.2% |
| Noise, audible | 1 | 0.3% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 45 | 11.9% |
| Inadequate osseointegration | 12 | 3.2% |
| Back painback pain | 10 | 2.6% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 8 | 2.1% |
| Numbnessnumbness | 7 | 1.9% |
| Neuropathy | 6 | 1.6% |
| Device embedded in tissue or plaque | 4 | 1.1% |
| Discomfortdiscomfort | 4 | 1.1% |
| Nonunion/delayed-union bone fracture | 4 | 1.1% |
| Paralysis | 4 | 1.1% |
| Muscle weakness/atrophy | 3 | 0.8% |
| Cerebrospinal fluid leakage | 2 | 0.5% |
| Cramp(s) /muscle spasm(s) | 2 | 0.5% |
| Cyst(s) | 2 | 0.5% |
| Intervertebral disc compression or protrusion | 2 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Catalyft PL Expandable Interbody System | Product code MAX | All MAUDE reports |
|---|---|---|---|
| Reports | 378 | 9,238 | 26,136,888 |
| Share of that pool | — | 4.1% | 0% |
| Classified as death, per 1,000 reports | 0 | 3 | 9 |
| Classified as injury | 25.1% | 35.6% | 36.2% |
| Classified as malfunction | 74.9% | 63.3% | 62.3% |
| Filed by the manufacturer | 99.5% | 97.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MAX
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| ELEVATE Spinal System | 386 | 46 | 0% |
| CAPSTONE Spinal System | 358 | 26 | 0.3% |
| Crescent Spinal System | 322 | 5 | 0.6% |
| Clydesdale Spinal System | 260 | 33 | 0.4% |
| CLYDESDALE PTC Spinal System | 222 | 5 | 0% |
| Pivox Oblique Lateral Spinal System | 255 | 5 | 0% |
| T-Pal Spacer Applicator Inner Shaft | 271 | 0 | 0% |
| T-Pal Spacer Applicator Knob | 185 | 0 | 0% |
| T-Pal Spacer Applicator Handle | 157 | 0 | 0% |
| Unknown Cage/Spacer | 280 | 4 | 0% |
| Unknown_Spine_Product | 596 | 24 | 0% |
| Orthopedic Manual Surgical Instrument | 1,143 | 0 | 0.2% |
| Collect No Qas Spine Anterior Stabilis | 269 | 0 | 0% |
| Verte-Stack Spinal System | 212 | 0 | 0.5% |
| Divergence Anterior Cervical Fusion System | 230 | 30 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Catalyft PL Expandable Interbody System reports
How many FDA reports name Catalyft PL Expandable Interbody System?
378 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 95 in the latest 12 months.
What kinds of events are reported?
malfunction (74.9%) and injury (25.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
mechanical problem (61.9%), migration (19.6%), mechanics altered (11.1%), break (5.6%) and device dislodged or dislocated (1.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Catalyft PL Expandable Interbody System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.